You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 24, 2024

~ Buy the OMIDRIA (ketorolac tromethamine; phenylephrine hydrochloride) Drug Profile, 2024 PDF Report in the Report Store ~

CLINICAL TRIALS PROFILE FOR OMIDRIA

✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for OMIDRIA

Subscribe to access the full database, or Try a Trial
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT02895035 ↗	Comparison of Epinephrine and Phenylephrine/Ketorolac With Regards to Pupil Size	Terminated	Milton S. Hershey Medical Center	Phase 4	2016-09-01	The objective of this study is to compare the maintenance of intraoperative mydriasis during cataract surgery between two drugs: epinephrine, which has routinely been used for decades, and Omidria, a newly FDA approved combination drug of phenylephrine and ketorolac. Patients undergoing cataract surgery that are enrolled in the trial will randomly receive one of the drugs in one eye, and the other eye will receive the drug during the subsequent cataract surgery.
NCT03864133 ↗	No Drop Post-Op Cataract Surgery	Completed	Omeros Corporation	Phase 4	2019-07-08	This study evaluates the effect of Intraocular Phenylephrine/Ketorolac Infusion on Retinal Thickness and Macular Edema in Cataract Surgery. Participants will receive infusions of Phenylephrine/Ketorolac during surgery instead of receiving topical NSAID drops pre and post operatively.
NCT03864133 ↗	No Drop Post-Op Cataract Surgery	Completed	Wake Forest University Health Sciences	Phase 4	2019-07-08	This study evaluates the effect of Intraocular Phenylephrine/Ketorolac Infusion on Retinal Thickness and Macular Edema in Cataract Surgery. Participants will receive infusions of Phenylephrine/Ketorolac during surgery instead of receiving topical NSAID drops pre and post operatively.
NCT04316936 ↗	Omidria and Dexycu, or Omidria and Dextenza Compared to Topical Prednisolone Acetate 1% Following Cataract Surgery	Recruiting	Ocular Therapeutix, Inc.	Phase 4	2019-12-10	This research will evaluate the efficacy of Omidria and Dexycu, Omidria and Dextenza, and Omidria and prednisolone acetate 1% in the resolution of post-operative inflammation and pain following cataract surgery.
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for OMIDRIA

Condition Name

Chart
Table

Condition Name for OMIDRIA
Intervention	Trials
Cataract	3
Cataract Surgery	1
Cystoid Macular Edema	1
Eye Diseases	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for OMIDRIA
Intervention	Trials
Cataract	4
Retinal Diseases	1
Macular Edema	1
Lens Diseases	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for OMIDRIA

Trials by Country

Map
Table

Trials by Country for OMIDRIA
Location	Trials
United States	2
Netherlands	1
Germany	1
Austria	1
Portugal	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for OMIDRIA
Location	Trials
Missouri	1
North Carolina	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for OMIDRIA

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for OMIDRIA
Clinical Trial Phase	Trials
Phase 4	4
Phase 3	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for OMIDRIA
Clinical Trial Phase	Trials
Recruiting	2
Terminated	1
Completed	1
[disabled in preview]	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for OMIDRIA

Sponsor Name

Chart
Table

Sponsor Name for OMIDRIA
Sponsor	Trials
Omeros Corporation	2
Milton S. Hershey Medical Center	1
Wake Forest University Health Sciences	1
[disabled in preview]	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for OMIDRIA
Sponsor	Trials
Other	6
Industry	3
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.